Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy
Jean Louis Lefèbvre(Centre Oscar Lambret), Dominique Chevalier(Hôpital Claude Huriez), É. Bardet(Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers), Frédéric Rolland(Institut de Cancérologie de l'Ouest), Lisa Licitra(University of Milan), Luigi Barzan(Azienda Ospedaliera Santa Maria Degli Angeli), Roger Stupp(University Hospital of Zurich), C. René Leemans(Amsterdam UMC Location VUmc), J. Bernier(Clinique de Genolier), Jan Bogaerts(European Organisation for Research and Treatment of Cancer), Lionnel Geoffrois(Institut de Cancérologie de Lorraine), Denis Lacombe(European Organisation for Research and Treatment of Cancer), D. De Raucourt(Centre Hospitalier Universitaire de Nantes), P. Hupperets(Maastricht University Medical Centre), F Lunghi(Ospedale Civile Di Ivrea), Jan B. Vermorken(University of Antwerp), Margot Tesselaar(Leiden University Medical Center), Jean-Claude Horiot(Radboud University Nijmegen)
Cited by 282
Related Papers
<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma
|New England Journal of Medicine|2005|7.2k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
|New England Journal of Medicine|2006|2.7k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k